Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)				1 Months Ended	3 Months Ended				6 Months Ended		9 Months Ended	12 Months Ended
	May 03, 2023 USD ($)	Apr. 12, 2023	Feb. 16, 2023	Apr. 30, 2019 shares	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) shares	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Mar. 31, 2023 USD ($) shares	Sep. 30, 2022 USD ($)
Accounts Receivable, Allowance for Credit Loss					$ 19,292				$ 19,292		$ 19,292	$ 36,980
Accounts Receivable, after Allowance for Credit Loss, Current					338,502				338,502		338,502	273,451
Revenue, Remaining Performance Obligation, Amount					0				0		0
Contract with Customer, Asset, after Allowance for Credit Loss, Total					0				0		0
Federal Deposit Insurance Corporation Premium Expense												250,000
Cash, Uninsured Amount					791,000,000,000				791,000,000,000		791,000,000,000	$ 5,800,000
Net Income (Loss) Attributable to Parent					(1,336,802)	$ (3,956,062)	$ (4,657,215)	$ (19,160,904)	(5,292,864)	$ (23,818,120)
Working Capital					$ 5,466,788				$ 5,466,788		$ 5,466,788
Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member]
Number of Major Customers					0				0
Manufacturing Equipment [Member]
Property, Plant and Equipment, Useful Life (Year)					5 years				5 years		5 years
Software [Member]
Property, Plant and Equipment, Useful Life (Year)					3 years				3 years		3 years
Minimum [Member]
MerchantProcessingFee					2.60%				2.60%		2.60%
Maximum [Member]
MerchantProcessingFee					5.00%				5.00%		5.00%
Subsequent Event [Member] | Public Offering [Member]
Proceeds From Issuance of Common Stock, Net	$ 2,500,000
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio		45
Reverse Stock Split [Member] | Minimum [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio			20
Reverse Stock Split [Member] | Maximum [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio			50
Reverse Stock Split [Member] | Subsequent Event [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio		45
Cure Based Development, Llc [Member] | Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares				338,889							87,307
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)				5 years
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares) | shares				338,889
Cure Based Development, Llc [Member] | Unregistered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares				194,445		48,612
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)				5 years
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares) | shares						338,889